Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CELH vs GSK✓SelectedUSD · GSKCELH vs GSK performance historyLatest closeAs of-6.20%11/19
Stock and ETF performance explorer

CELH vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+130.4%
GSK return
+128.8%
Excess return
+1.6%
Maximum drawdown
-99.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-6.2%-1.6%-4.6%-5.6%
7D-3.7%-4.7%+1.0%-1.9%
30D+2.5%-4.7%+7.2%+4.3%
3M-4.8%-8.8%+4.0%-1.6%
6M+5.5%-4.6%+10.1%+6.8%
YTD-32.8%+1.0%-33.8%-33.9%
1Y-25.4%+6.9%-32.3%-28.2%
3Y-38.5%+52.5%-91.1%-49.8%
5Y+26.5%+40.3%-13.8%+4.7%
10Y+3,756.1%+99.0%+3,657.1%+2,630.9%
All+130.4%+128.8%+1.6%+60.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling